- Luteinizing-hormone releasing hormone (LHRH) agonist drugs are commonly prescribed for both Prostate and Breast Cancers.
- Controlling the hormones that trigger cancer cell development has proven effective but requires long term management.
- Medically treatable
Luteinizing-hormone releasing hormone (LHRH) agonist, is widely prescribed for Prostate and Breast Cancer treatment.
In breast cancer patients LHRH is typically used to reduce the risk of early-stage, hormone-receptor-positive breast cancer coming back in premenopausal women after surgery and other treatments.
For prostate cancer, the drug prevents the testicles from receiving messages to make testosterone. Hormone therapy is used in men with advanced prostate cancer to shrink the cancer and slow the growth of tumors. In men with early-stage prostate cancer, hormone therapy may be used to shrink tumors before radiation therapy. This can make it more likely that radiation therapy will be successful.